
    
      The study will be conducted in 2 stages: a 3-dose primary vaccination at 2, 4 and 6 months of
      age and a booster vaccination at 12 to 15 months of age. All subjects will have 3 blood
      samples taken. Half of the subjects of each group will have a blood sample taken just prior
      to the administration of the third dose of the primary vaccination and the other half of the
      subjects of each group will have a blood sample taken at one month after the third vaccine
      dose of the primary vaccination phase. In addition, all subjects of all groups will have a
      blood sample taken before and 42 days after administration of the booster dose.
    
  